Prosight Management, LP Shattuck Labs, Inc. Transaction History

Prosight Management, LP

$348 Million
Q1 2024

A detailed history of Prosight Management, LP transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Prosight Management, LP holds 3,725,000 shares of STTK stock, worth $13.6 Million. This represents 9.58% of its overall portfolio holdings.

Number of Shares

3,725,000

Previous 2,782,797 33.86%

Holding current value

$13.6 Million

Previous $19.8 Million 67.84%

% of portfolio

9.58%

Previous 8.38%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$7.37 - $10.09 $6.94 Million - $9.51 Million	942,203 Added 33.86%	3,725,000 $33.3 Million
Q4 2023 Feb 14, 2024	BUY	$1.37 - $7.24 $903,921 - $4.78 Million	659,797 Added 31.08%	2,782,797 $19.8 Million
Q3 2023 Nov 14, 2023	BUY	$1.42 - $3.16 $18,999 - $42,280	13,380 Added 0.63%	2,123,000 $3.23 Million
Q2 2023 Aug 14, 2023	BUY	$2.52 - $3.66 $221,639 - $321,904	87,952 Added 4.35%	2,109,620 $6.58 Million
Q1 2023 May 12, 2023	SELL	$2.5 - $4.72 $229,562 - $433,414	-91,825 Reduced 4.34%	2,021,668 $5.94 Million

Q4 2022 Feb 14, 2023	BUY	$1.96 - $3.26 $1.95 Million - $3.24 Million	992,717 Added 88.57%	2,113,493 $4.86 Million
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.52 $262,017 - $556,283	100,776 Added 9.88%	1,120,776 $3.03 Million
Q2 2022 Aug 12, 2022	BUY	$2.7 - $4.59 $597,461 - $1.02 Million	221,282 Added 27.7%	1,020,000 $4.14 Million
Q1 2022 May 16, 2022	BUY	$4.22 - $8.89 $2.27 Million - $4.79 Million	538,475 Added 206.91%	798,718 $3.4 Million
Q4 2021 Feb 14, 2022	BUY	$8.36 - $21.08 $760,776 - $1.92 Million	91,002 Added 53.77%	260,243 $2.22 Million
Q3 2021 Nov 12, 2021	BUY	$17.57 - $28.95 $2.97 Million - $4.9 Million	169,241 New	169,241 $3.45 Million

Others Institutions Holding STTK

# of Institutions

Shares Held

23.3M

Call Options Held

130K

Put Options Held

163K

View Full List

About Shattuck Labs, Inc.

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $154M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

More about STTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Account

Prosight Management, LP Shattuck Labs, Inc. Transaction History